v3.26.1
BUSINESS SEGMENT
6 Months Ended
Jun. 30, 2026
BUSINESS SEGMENT  
BUSINESS SEGMENT

9.    BUSINESS SEGMENT

The Company operates in a single reportable segment, referred to as safety medical syringes and other safety medical devices. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources and evaluating financial performance.  The accounting policies of our single reportable segment are the same as those for the Company as a whole.

The following are summaries of the Company’s sales and long-lived assets by geography:

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

  ​ ​ ​

June 30, 2026

  ​ ​ ​

June 30, 2025

  ​ ​ ​

June 30, 2026

  ​ ​ ​

June 30, 2025

U.S. sales

$

5,873,520

$

8,489,677

$

11,821,845

$

15,921,987

North and South America sales (excluding U.S.)

 

1,176,924

 

1,745,436

 

2,032,774

 

2,298,936

Other international sales

 

150,179

 

210,620

 

523,401

 

519,983

Total sales

$

7,200,623

$

10,445,733

$

14,378,020

$

18,740,906

Long-lived assets by geography are as follows:

  ​ ​ ​

June 30, 2026

  ​ ​ ​

December 31, 2025

Long-lived assets

U.S.

$

72,459,059

$

75,996,168

International

3,006,044

3,183,881

Total

$

75,465,103

$

79,180,049